Jean-Phillippe Metges

7PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade

|Aug 01, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study.

Philip A Philip, Vaibhav Sahai, Nathan Bahary

|Jul 25, 2023
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma.

Samuel J Klempner, Keun-Wook Lee, Kohei Shitara

|Jan 21, 2023
Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time?

Vincent Bourbonne, Ulrike Schick, Olivier Pradier

|Jul 14, 2022
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Manish A Shah, Kohei Shitara, Florian Lordick

|Jun 11, 2022
Global trends in oncology research: A mixed-methods study of publications and clinical trials from 2010 to 2019.

Vincent Akiki, Xavier Troussard, Jean-Philippe Metges

Pageof 2

Frequent Collaborators

2 joint publications

David Tougeron

2 joint publications

Michel Ducreux

2 joint publications

Kohei Shitara

2 joint publications

Rosine Guimbaud